These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 6338150

  • 41. The pharmacology of ototoxic drugs.
    Harpur ES.
    Br J Audiol; 1982 May; 16(2):81-93. PubMed ID: 7093567
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Therapy and prevention of ototoxic lesions caused by antibiotics].
    Shevtsov VM.
    Vestn Otorinolaringol; 1971 May; 33(4):19-22. PubMed ID: 5112390
    [No Abstract] [Full Text] [Related]

  • 44. [Early diagnosis, prevention and treatment of hearing disorders occurring following the intake of antibiotics].
    Giul'khasian AA.
    Zh Ushn Nos Gorl Bolezn; 1973 May; 33(6):8-12. PubMed ID: 4786993
    [No Abstract] [Full Text] [Related]

  • 45. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.
    Parsons SK, Neault MW, Lehmann LE, Brennan LL, Eickhoff CE, Kretschmar CS, Diller LR.
    Bone Marrow Transplant; 1998 Oct; 22(7):669-74. PubMed ID: 9818694
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Aminoglycoside-induced ototoxicity.
    Selimoglu E.
    Curr Pharm Des; 2007 Dec; 13(1):119-26. PubMed ID: 17266591
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
    de Jager P, van Altena R.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Topical antibiotics: strategies for avoiding ototoxicity.
    Haynes DS.
    Ear Nose Throat J; 2004 Jan; 83(1 Suppl):12-4. PubMed ID: 14986398
    [Abstract] [Full Text] [Related]

  • 59. Drug-related nephrotoxic and ototoxic reactions : a link through a predictive mechanistic commonality.
    Verdel BM, van Puijenbroek EP, Souverein PC, Leufkens HG, Egberts AC.
    Drug Saf; 2008 Jan; 31(10):877-84. PubMed ID: 18759511
    [Abstract] [Full Text] [Related]

  • 60. Biochemical basis of aminoglycoside ototoxicity.
    Schacht J.
    Otolaryngol Clin North Am; 1993 Oct; 26(5):845-56. PubMed ID: 8233493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.